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In vitro selection of a novel nuclease-resistant RNA
phosphodiesterase
Amber Beaudry1, James DeFoe1, Shawn Zinnen1, Alex Burgin2 and
Leonid Beigelman1
Background: Ribonucleotide-based enzymes (ribozymes) that cleave
pathological RNAs are being developed as therapeutic agents. Chemical
modification of the hammerhead ribozyme has produced nuclease-resistant
catalysts that cleave targeted mRNAs in cell culture and exhibit antitumor
activity in animals. Unfortunately, stabilizing modifications usually reduce the
catalytic rate in vitro. An alternative to rationally designed chemical
modifications of existing ribozymes is to identify novel motifs through in vitro
selection of nuclease-stable sequence space. This approach is desirable
because the catalysts can be optimized to function under simulated
physiological conditions.
Results: Utilizing in vitro selection, we have identified a nuclease-stable
phosphodiesterase that demonstrated optimal activity at simulated physiological
conditions. The initial library of 1014 unique molecules contained 40 randomized
nucleotides with all pyrimidines in a nuclease-stabilized 2′-deoxy-2′-amino
format. The selection required trans-cleaving activity and base-pairing specificity
towards a resin-bound RNA substrate. Initial selective pressure was permissive,
with a 30 min reaction time and 25 mM Mg2+. Stringency of selection pressure
was gradually increased until final conditions of 1 mM Mg2+ and less than 1 min
reaction times were achieved. The resulting 61-mer catalyst required the
2′-amino substitutions at selected pyrimidine positions and was stable in human
serum (half-life of 16 h). 
Conclusions: We demonstrated that it is possible to identify completely novel,
nuclease-resistant ribozymes capable of trans-cleaving target RNAs at
physiologically relevant Mg2+ concentrations. The new ribozyme motif has minimal
substrate requirements, allowing for a wide range of potential RNA targets.
Introduction
The ability of catalytic RNA [1,2] to specifically bind and
cleave other RNAs has been recognized as method of
controlling gene expression [3]. The hammerhead
ribozyme, being the smallest natural phosphodiesterase,
has been chemically modified to function in a therapeutic
setting [4,5]. This stabilization increased nuclease resis-
tance while maintaining catalytic activity and has pro-
duced ribozymes capable of down-regulating gene
expression in vitro and in vivo [6–9]. Several stabilized
hammerhead ribozymes are currently being evaluated in
human clinical trials [8].
The discovery of catalytic RNA has also generated a
search for new ribozymes of natural origin (for reviews, see
[10–12]) that may also have therapeutic value, and chal-
lenged scientists to find ribozymes capable of catalyzing a
diverse set of chemical reactions [13–16]. In vitro selection
has been used to develop new catalysts or optimize exist-
ing ribozymes [17–19]. For example, attempts have been
made to select from libraries ribozymes containing fea-
tures of the hammerhead [20–26]. These selections have
been done in an all-ribonucleotide format and have there-
fore required subsequent nuclease stabilization. Stabiliz-
ing chemical modifications, with rare exceptions [27,28],
cause a decrease in the cleavage rate in vitro [4,5]. Other
selections have been performed and have identified an
AUG-cleaving hammerhead-like ribozyme as a new
purine-specific ribozyme motif [29]. It remains to be seen
whether this ribozyme will be amenable to stabilizing
chemical modifications.
The need to identify chemically stable nucleic acid cata-
lysts led to the development of the first deoxyribonu-
cleotide catalyst [30]. It was shown that a 14-mer
oligodeoxynucleotide could catalyze the cleavage of a
35-mer RNA substrate, but with lower catalytic efficiency
than partially substituted hammerhead ribozymes. This
was followed by the discovery that DNA could perform
phosphodiester cleavage of RNA in the presence of Pb2+
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[31], and led to the selection and characterization of mag-
nesium-dependent DNA enzymes [32,33]. The smallest
of these is 31 deoxynucleotides and cleaves RNA in trans
with kcat/Km in the range of 108 M–1 min–1 at 2 mM MgCl2
[34]. Application of this motif in cell culture has shown
specific knockdown of target mRNA in model systems
[35–37]. Although DNA is generally less sensitive to
nuclease degradation, unmodified DNA enzymes were
broken down in 10% fetal bovine serum and in human
serum [34,35,37]. Chemical modifications increased the
extent of protection from degradation and have been
shown to be effective in cell culture models. 
We designed a selection that explored nuclease-stable
sequence space by using 2′-deoxy-2′-aminopyrimidine
nucleotides. The selective pressures required trans-cleav-
age and were moved towards physiological ion concentra-
tions. A novel non-hammerhead-like ribozyme with
inherent nuclease stability and optimal activity under
physiological conditions was generated. To the best of our
knowledge, this is the first demonstration that nuclease-
resistant ribozymes can be directly evolved through an
in vitro selection approach.
Results and discussion 
In vitro selection scheme and initial selection of active pool
We designed a selection scheme to mimic what is required
of a therapeutic ribozyme in vivo: bind the target RNA
through specific base-pairing interactions and, in a trans
reaction, cleave the target RNA under physiological condi-
tions. 2′-deoxy-2′-aminopyrimidine nucleotides were used
to generate a chemically stabilized RNA sequence pool.
The initial pool (N = 40) contained 3 × 1014 individual
sequences transcribed using a T7 RNA polymerase with
2′-amino-dCTP/2′-amino-dUTP and normal ATP/GTP.
To increase the amount of this modified RNA product,
transcription conditions were optimized by inclusion of
methanol [38] and lithium chloride in the reaction buffer.
The 2′-amino-2′-deoxynucleotides do not interfere with
the reverse transcription and amplification steps of selec-
tion and confer nuclease resistance [39]. This inherent
nuclease resistance offers an advantage over unmodified
hammerhead ribozymes and DNA enzymes, while also
allowing for unique tertiary interactions not possible with
2′-OH or 2′-H.
We designed the RNA in the pool to have two binding
arms, complementary to a specific substrate RNA, sepa-
rated by 40 random nucleotides (Figure 1). The 16-mer
substrate had two binding domains, 5 and 10 nucleotides
long, separated by an unpaired guanosine. The two
binding domains in the substrate RNA bind to the two
binding arms in the pool to form 15 base pairs (5/10). The
5′-end of the substrate had a biotin molecule attached
through a C18 linker. The substrate was linked to a Neutr-
Avidin resin and the selection was performed in a column
format [22]. The desired reaction was cleavage at the
unpaired G upon addition of magnesium. Subsequent
instability of the product (five base pair helix) allowed dis-
sociation from the column. The predicted dissociation con-
stant at 37°C (Kd37°C) for dissociation of an active species
with the 5′-portion of cleaved substrate was calculated to
be 43 µM, whereas the predicted Kd37°C for any member of
the random population to hybridize to the 16-mer sub-
strate is 2 × 10–8 nM [40]. The actual Kd37°C could differ
because the 2′-amino modification confers decreased ther-
modynamic stability in duplex formation [41], so we per-
formed model experiments to characterize column
behavior. After the substrate was linked to the column, the
pool was added in column buffer (50 mM Tris–HCl,
pH 8.5, 100 mM NaCl, 50 mM KCl) and allowed to bind.
The column was washed until the amount of pool coming
off the column was reduced to background levels. More
than 60% of the initial pool was bound at this point. Incu-
bation with elution buffer containing 25 mM MgCl2 for
30 min resulted in background levels of pool coming off
the column; we thus believed that the binding of pool to
substrate was stable. The pool bound to the column could
then be eluted using 7M urea, indicating that the binding
is reversible. A control column with no substrate linked
was run in parallel and showed that the column binding is
specific to the presence of substrate. Pool ‘eluted’ follow-
ing the incubation with MgCl2 was precipitated, amplified
and transcribed as described in the Materials and methods
section. This constitutes one round of selection. Initially,
selection was done with permissive cleavage conditions
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Figure 1
Scheme for 2′-amino-dCTP/dUTP trans
selection. Randomized RNA pool with
engineered binding arms is allowed to base
pair with column-bound substrate. Exposure
to magnesium allows for potential cleavage of
substrate at unpaired G and dissociation
from column.
5’-GGAAAG GUGUGCAACC N40ACGGC CCUUUA...........
  3’- CACACGUUGG  G UGCCG
N40 pool (randomized region  with 2¢ -Amino U,C)
Biotin-NeutrAvidin-Column
 
5 bp10 bp
Cleavage site
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(25 mM Mg2+, pH 8.5,  100 mM NaCl, 50 mM KCl,
30 min, 25°C). This allowed the presumably small number
of catalysts with any cleavage activity to survive the selec-
tion. The selection conditions were then made more strin-
gent to identify catalysts with robust catalytic efficiencies
under physiological conditions.
After eight rounds of selection, we saw no activity in a
single turnover kinetic assay (under the selection condi-
tions of 25 mM MgCl2, 50 mM Tris–HCl, pH 8.5, 100 mM
NaCl, 50 mM KCl). We decided to make the selection
more stringent. We modified the substrate such that the
10-base-pair interaction between one of the binding arms
of the RNA pool and substrate became 16 base pairs (5/16)
and, therefore, binding was made more stable. The Kd
measured by gel-shift assay went from 31 nM (5/10) to
3 nM (5/16); the Kd of one of the product pieces alone (16-
mer) was 4 nM (data not shown). Because product dissocia-
tion is expected to be slow, ribozymes that come off the
column as a result of a cleavage event would stay bound to
its 3′ product (16-mer). The eluent was then passed
through an additional ‘product’ column that had the 16
nucleotide 3′ fragment of substrate attached through the
same chemistry as original substrate. It was anticipated that
this column would bind any individual that was eluted
from the first column through a noncleavage event (i.e. dis-
sociation), whereas ribozyme with clevage product bound
should flow through. This eluent was precipitated and
amplified as previously described. After three more rounds
in this format (generation 11), there was visible activity in a
single turnover cleavage assay (3% cleaved at 4 h,
Figure 2). By generation 13 (G13), 45% of the substrate
was cleaved at 4 h; the observed rate constant (kobs) of the
pool was 0.037 min–1 in 25 mM MgCl2. We subcloned and
sequenced G13; the pool was still very diverse (data not
shown). Because our goal was to obtain a ribozyme that
would work in a physiological environment, we decided to
change selection pressure rather than exhaustively catalog
G13 members.
Optimization of initial active pool at physiological
conditions
Optimization of the N40 pool was started from the G12
DNA pool. Part of the G12 pool DNA was subjected to
hypermutagenic PCR [42] to introduce a 10% per position
mutation frequency and was designated N40H. At round
19, part of the DNA was hypermutagenized again, giving
N40M and N40HM (a total of four parallel pools). The
column substrates remained the same; temperature of
binding and elution was raised to 37°C. Column buffer was
replaced by physiological buffer (50 mM Tris–HCl,
pH 7.5, 140 mM KCl, 10 mM NaCl) and elution buffer was
replaced by 1 mM Mg buffer (physiological buffer +1 mM
MgCl2). The amount of time allowed for the pool to bind
to the column was eventually reduced to 10 minutes and
elution time was gradually reduced from 30 minutes to
20 seconds (Figure 3). Between rounds 18 and 23, kobs for
the initial N40 pool stayed relatively constant at
0.035–0.04 min–1. At generations 21–22, all four pools
started to display similar kobs values (0.035–0.04 min–1),
indicating that the selection was complete. G22 from each
of the four pools was cloned and representative members
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Figure 2
Progress of initial selection as measured by the cleavage assay. Pools
were incubated under single-turnover conditions with labeled substrate
and quenched after 4 h. Amount of substrate converted to product is
shown. G, generation; reaction conditions: 50 mM Tris–HCl, pH 8.5,
100 mM NaCl, 50 mM KCl, 25 mM MgCl2, 37°C, 10 nM pool, < 1 nM
substrate (5′-32P-GCC GUG GGU UGC ACA C-3′). 
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Figure 3
Progress of optimization under physiological conditions (37°C, 50 mM
Tris—HCl, pH 7.5, 140 mM KCl, 10 mM NaCl) as measured by column
behavior. Percentage of bound pool eluting from column is shown. As
signal rose, additional pressure was exerted on the pool in the form of
reduced time of exposure to the magnesium-containing elution buffer.
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were sequenced. From each pool, 36 clones were
sequenced and were found to be variations of the same
consensus motif (Figure 4, Table 1). RNA from unique
clones was assayed for activity in 1 mM MgCl2 and physio-
logical conditions; clone 1-9 represented the consensus
sequence and was used in subsequent experiments. 
Once selection was completed, we proceeded with initial
characterization of the new ribozyme. This included four
steps: first, truncations to determine the functional size of
the new motif; second, initial kinetic and mechanistic
characterization — kcat/Km, pH and Mg2+ dependence of
the rate were determined to allow comparison with other
ribozymes; third, substrate recognition rules to assess gen-
erality in targeting mRNA of interest; fourth, nuclease
resistance as a major parameter for in vivo applications. 
Initial characterization of new ribozyme motif
To make the motif shorter, we deleted the 3′-terminal 25
nucleotides necessary to bind the primer for amplification
1-9t. The measured rates of the full-length and truncated
molecules were both 0.04 min–1 (data not shown); thus, we
were able to reduce the size of the motif from 86 to 61
nucleotides (Figure 4). 
Single turnover kinetic measurement of 1-9t in physiolog-
ical conditions on an 18-mer substrate (binding arms 5/12)
is shown in Figure 5. The kcat of this ribozyme is
0.0319 ± 0,0007 min–1 and Km is 8.67 ± 0.89 nM (close to
the 3 nM Kd measurement for pool RNA in the absence
of MgCl2), giving a kcat/Km measurement of
3.7 × 106 min–1 M–1. The 1-9t ribozyme is capable of
turnover — with 20-fold excess of substrate, 100 nM
ribozyme turns over at a rate of once every 2 h. This
slower rate is probably the result of slow product release,
as one arm of the ribozyme forms 16 base pairs with the
substrate RNA. 
This novel ribozyme catalyzes cleavage of a specific phos-
phodiester bond; the resultant products contain a
2′,3′-cyclophosphate and a 5′-OH. This was determined in
two ways. First, the 5′ product, a 5′-32P-6-mer, was run on
a 20% sequencing gel with both alkaline ladder and
RNase T1 ladder. The product had the same migration as
fragments in the ladders, which contain 2′,3′-cyclophos-
phates. Second, we were able to kinase the 3′-16-mer
product, indicating that it had a free 5′-OH. 
The 1-9t motif has low magnesium dependence (Figure 6)
with maximal activity at 2 mM MgCl2, very close to the
selection conditions. Using magnesium as the divalent
metal, the DNA enzyme shows increasing activity with
increasing Mg2+ concentrations in a simulated physiological
buffer (as measured out to 300 mM MgCl2 in 50 mM EPPS
pH 7.5, 150 mM NaCl, 37°C) [34]. Interestingly, the ham-
merhead ribozyme shows a log-linear response to increas-
ing amounts of magnesium (at pH 7.2 in 50 mM MOPS
and 0.5 mM spermine, 25°C) [43]. For comparison, we
measured the magnesium dependence of the well-charac-
terized Hammerhead 16, in our buffer [44]. Surprisingly,
Hammerhead 16 showed reduced magnesium require-
ments in pseudo-physiological conditions (Figure 6), most
likely a result of the higher concentration of monovalent
salts [45]. This result is also supported by intracellular
cleavage rates by hammerhead ribozymes in the order of
0.1 min–1 (A. McCaffrey and O. Uhlenbeck, personal com-
munication) and may be a function of its occurrence in
nature. Chemical stabilization of Hammerhead 16 [8],
using modifications relevant to therapeutic ribozymes in
clinical trials, reduces cleavage activity in vitro (Figure 6)
and demonstrates magnesium dependence to be similar to
that shown in previous studies [43]. 
This ribozyme, 1-9t, also showed distinct pH dependence
of cleavage rates (Figure 7). Below pH 7.0, the motif is
inactive, which is not suprising given the pKa of the
2′-amino group (pKa = 6.5) in 2′-deoxy-2′aminouridine and
cytidine [41]. Between pH 7.0 and pH 9.0, there is a linear
response in activity with a slope of 0.5. Although it has
been suggested that a single deprotonation occurs with
the hammerhead ribozyme mechanism (a slope of 0.7 that
was considered to be sufficiently close to 1) [43] and with
the DNA enzyme [34], the slope observed for the 1-9t
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Figure 4
Secondary structure representation of consensus motif (1-9t), cloned
from generation 22. Nucleotides 61–84 were part of the primer-
binding site for amplification, a potential site of truncation.
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motif is too low for a single deprotonation event to explain
the mechanism of activity. 
Secondary structure, substrate recognition rules and
nuclease resistance
Several lines of evidence support the overall secondary
structure of 9-1t clone represented in Figure 4, originally
derived from the Zuker fold [46]. Analysis of phylogenic
data on 134 clones demonstrated that no mutations signifi-
cantly increased activity; most of the mutations were in
regions believed to be duplex, based on the proposed sec-
ondary structure (Figure 4, Table 1). Quite characteristic
are mutations in proposed base pair U19–A34. Mutations
that maintain this base pair U19–A34 supports ribozyme
activity (Krel = 1.01); mutations that do not support this base
pair (A19–A34 and U19–U34), and therefore can destabilize
stem 2 close to what may be catalytic core (G17–C36;
C37–A42; G54–G56), are detrimental to cleavage activity
(Krel = 0.02 and 0.22, respectively). Additional examples of
compensatory mutations in stem 2 can be found in positions
(base pairs) U21–G32 and A23–U30. In general, we did not
observed many mutations that support activity in the
stem–loop 3 region, indicating that this part of the ribozyme
is more conserved and may be a part of a catalytic core
rather than a supporting structural aliment. A C52→U52
mutation that maintains proposed base pair G44–C52  is
well tolerated, as are mutations in the loop (C49→U or A).
The 2′-amino-2′-deoxy C is absolutely required for cata-
lytic activity; an all-ribo-substituted 1-9t does not have any
cleavage activity in vitro. Substitution of ribo-U during
transcription for 2′-amino-2′-deoxy U resulted in a mol-
ecule with a tenfold decrease in catalytic rate. In addition,
substitution of ribo-C during transcription for 2′-amino-
2′-deoxy C resulted in a completely inactive molecule. It
is notable that a stretch of 2′-NH2-pyrimidine nucleotides
Research Paper  Nuclease-resistant RNA phosphodiesterase Beaudry et al. 327
Table 1
Random region alignments/mutations.
Position
Clone (No.) 17 20 30 40 50 56 Krel
1-9 motif (42) G G U G U C A U C A U A A U G G C A C C C U U C A A G G A C A U C G U C C G G G 1.01
1.1 (39) A* U* 0.89
1.6 A 1.06
1.27 A* C U* 0.95
1.14 (8) A 0.82
1.16 (5) A* C U* 0.66
1.20. A* A U* A 0.61
1.24 U G 0.75
1.30. A* U* U 0.81
2.1 C C 0.24
2.13 A* U* G 0.19
2.18 (3) A A 0.02
2.34 A A 0.62
2.21 C A C 0.25
2.23 (2) U 0.9
2.27 A* C G U 0.78
2.31 U 1.1
2.35 A* C C U* 0.84
2.36 A* U* A 0.31
2.38 (2) A* G U* 0.81
2.45 (2) A* C U* 0.36
3.3 C G 0.6
3.6 A A 1.11
3.7 A* C A U* 0.98
3.9 U 0.86
3.26 A* C U* 1.51
3.27 (2) U 0.22
3.28 (2) G 1.1
4.13 (3) A* A U* 0.95
4.19 A 0.44
4.34 (2) A* U* C 0.27
4.38 (3) C 0.97
Alignment of the random region from 134 clones from generation 22
(1.x = N40, 2.x = N40M, 3.x = N40H, 4.x = N40HM). The number of
copies of each mutant is in parentheses. Deviations from the
consensus sequence are shown. Mutations that maintain base pair
U19–A34 are marked with an asterisk. Activity in single turnover
kinetic assay is shown relative to G22 pool rate (50 mM Tris–HCl,
pH 7.5, 140 mM KCl, 10 mM NaCl, 1 mM MgCl2, 50 nM ribozyme,
trace substrate, 37°C). 
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C36–C40 is a part of highly conserved sequence situated
in a four-way junction across from the cleavage site guano-
sine. Interestingly, it was hypothesized recently, based on
crystal structure determination [47] and imidazole rescue
experiments [48], that the cytosine base at position 76 of
the HDV ribozyme is directly involved in a chemical step
of the cleavage mechanism of this ribozyme. 
We also explored the effects of possible truncations in
the stem–loop 2 and stem–loop 3 structures (Figure 8).
Truncation of three base pairs in stem–loop 2, with reten-
tion of the original AUAC loop or replacement with a
more stable GAAA tetraloop, resulted in a 2–4-fold
reduction of activity. It is also possible to truncate an
additional base pair with the addition of GAAA tetraloop
(Krel = 0.23). Application of the same strategy for trunca-
tion of stem–loop 3 while maintaining a full-length
stem–loop 2 appeared to be more challenging. Deletion
of two distal base pairs with the original AUC triloop
retained resulted in more than tenfold decrease in activ-
ity. We therefore substituted the AUC triloop in the orig-
inal motif with a standard GAAA tetraloop in anticipation
that this should stabilize the four base pair stem–loop 3
structure. This change allowed subsequent truncation of
one (Krel = 1.13) and even two base pairs (Krel = 0.78) in
stem–loop 3. 
Initial characterization of substrate recognition rules for
the 1-9t motif was tested by systematic replacement of
base pairs 3′ and 5′ of the cleavage site G, as well as by
investigation of the cleavage site nucleotide requirements
in wild type 1-9t. The requirements for the cleavage site
guanosine nucleotide are rather strict: only uridine is toler-
ated, but with sixfold decrease in cleavage activity. At the
same time, there are no strict sequence requirements for
328 Chemistry & Biology 2000, Vol 7 No 5
Figure 5
Single-turnover kinetic measurement of the 1-9t motif. Using the
Michaelis–Menten equation, kcat = 0.032 ± 0.0007 min–1 and
Km = 8.67 ± 0.89 nM. Reaction conditions: 50 mM Tris-HCl, pH 7.5,
140 mM KCl, 10 mM NaCl, 1 mM MgCl2, 5 nM ‘5/12’ substrate
(5′-GCCGU G GGUUGCAC ACCU-3′), 37°C.
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Figure 6
Magnesium dependence of 1-9t motif (circles), hammerhead 16
(HH16; squares) and chemically stabilized HH16 (diamonds).
Conditions for single turnover assay: 50 mM Tris–HCl, pH 7.5,
140 mM KCl, 10 mM NaCl, 100 nM ribozyme, 5 nM substrate, 37°C.
‘5/12’ substrate (5′-GCCGU G GGUUGCAC ACCU-3′) was used for
1-9t. HH16 = 5′-GCG AUG ACC UGA UGA GGC CGA AAG GCC
GAA ACG UUC CC-3′; HH16 substrate = 5′-GGG AAC GUC GUC
GUC GC-3′; chemically stabilized HH16 = 5′-gscsgs asug acc UGA
uGa ggc cga aag gcc Gaa Acg uuc ccB (lower case = 2′-O-methyl
nucleotide, upper case = ribonucleotide, U = 2′-C-allyl nucleotide,
s = phosphorothioate linkage, B = 3′-3′ inverted abasic).
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Figure 7
Dependence on pH of 1-9t motif. Linear curve fit gives a slope of 0.53.
Single turnover kinetics: 50 mM buffer, 140 mM KCl, 10 mM NaCl, 1 mM
MgCl2, 100 nM 1-9t ribozyme, 5 nM ‘5/12’ substrate (5′-GCCGU G
GGUUGCAC ACCU-3′), 37°C. pH 7.0–8.5 with Tris–HCl as buffer;
pH 8.92 with CHES as buffer. Activity was also tested at pH 6.0 and 6.5
(with MES as buffer) and there was no detectable cleavage.
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base pairs surrounding the cleavage site G (Table 2), only
slight preferences for pyrimidine bases both 3′ and 5′ of
the cleavage site.
By design, the 1-9t motif contained asymmetric binding
arms (16 and 5) as required by the selection scheme.
Truncation of the ‘long’ arm from 16 to 10 nucleotides did
not disrupt cleavage activity (Table 2), indicating that the
ribozyme function was not dependent on arm length
greater than 10 base pairs. Furthermore, complete replace-
ment of the substrate sequence with corresponding base
pairs maintaining changes in recognition arms resulted in
fully active ribozyme, confirming its general utility.
Stability of the motif was measured in human serum using
a chemically synthesized version of 1-9t. This version con-
tained a 3′–3′ inverted abasic deoxynucleotide at the
3′ end of the molecule. The half-life of synthetic 1-9t was
15.5 h, and results showed protection of the pyrimidine
residues to nuclease (Figure 9). Very few degradation
products were seen; rather, there was a disappearance of
counts over time. Unstabilized hammerhead ribozymes
show immediate degradation in human sera [4]; modified
hammerhead ribozymes show prolonged half-life in
serum. The DNA enzyme, with no modifications, shows
degradation products as early as 5 min [35,37]; addition of
modifications increased stability.
One should realize that nuclease stabilization against
human sera represents only the first step toward a thera-
peutic ribozyme. Extensive studies on in vivo pharmaco-
kinetic of antisense oligonucleotides [49] and stabilized
hammerhead ribozyme [50] demonstrated that although
sera stability is predictive for in vivo behavior, additional
stabilization is often required. In particular, 3′ and 5′
modifications as well as additional stabilization of remain-
ing ribo- or deoxy-positions through backbone (monoth-
ioate or dithioate) or 2′ modifications can significantly
improve in vivo stability and pharmacological profile of
the target molecules.
Selection of new ribozyme motifs utilizing modified
nucleoside 5′-triphosphates
It is well recognized that, despite impressive credentials,
RNA and DNA enzymes are not yet as effective catalysts
as protein enzymes. Narlikar and Herschlag discussed
several explanations of this phenomenon in their compre-
hensive and insightful review [51]. In their summary, they
emphasized that the low diversity of RNA/DNA
sidechains, as well as the high charge and flexibility of
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Figure 8
Representation of stem truncation and loop
replacement analysis. Krel is for the 61-mer 
1-9t, measured as described in Table 2.
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phosphodiester backbone that result in RNA/DNA’s com-
promised ability to create an extensive hydrophobic
pocket(s) of low dielectric and limited rigidity to achieve
precise positioning are among major factors contributing to
deficiency of RNA/DNA-based enzymes compared with
protein enzymes.
A straightforward way to address these shortcomings
seems to be the addition of a new ‘protein-like’ function-
alities to RNA/DNA utilizing modified nucleoside
triphosphates suitable for in vitro selection protocols [52].
However, practical realization of this seemingly simple
idea has so far achieved only limited success. To date,
only two selections with modified triphosphates have pro-
duced new catalysts. Eaton and coworkers [53] reported
selection of RNA amide synthase with a rate enhance-
ment factor of 104 over the uncatalyzed reaction. In this
selection, they used 5-imidazole-UTP instead of UTP and
the catalytic core of selected enzyme contained three
5-imidazole–uridine nucleotides. The substitution of
these conserved modified uridine residues for UTP abol-
ished ribozyme activity. Another report from Eaton’s
group [54] disclosed successful selection of the RNA
ribozyme catalyzing carbon–carbon bond formation in
Diels–Alder reaction with 800-fold rate enhancement. In
this case, 5-pyridylmethylcaboxamide–UTP was utilized
as a modified triphosphate instead of UTP, and earlier
selection attempts without this modified nucleotide were
unsuccessful [55]. Recent development of the series of
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Table 2
Substrate requirements for 1-9t motif.
Substrate sequence 1-9t mutation krel
5′-GCCGU G GGUUGCAC ACCUUUCC-3′ wt 1.00
5′-GCCGU G GGUUGCAC ACCUUUCC-3′ A57G 2.5
5′-GCCGA G GGUUGCAC ACCUUUCC-3′ A57U 0.24
5′-GCCGC G GGUUGCAC ACCUUUCC-3′ A57G 0.66
5′-GCCGG G GGUUGCAC ACCUUUCC-3′ A57C 0.57
5′-GCCGU U GGUUGCAC ACCUUUCC-3′ wt 0.17
5′-GCCGU A GGUUGCAC ACCUUUCC-3′ wt n.d.
5′-GCCGU C GGUUGCAC ACCUUUCC-3′ wt n.d.
5′-GCCGU G GGUUGCAC ACCUUUCC-3′ C16U 0.98
5′-GCCGU G UGUUGCAC ACCUUUCC-3′ C16G n.d.
5′-GCCGU G UGUUGCAC ACCUUUCC-3′ C16A 0.65
5′-GCCGU G AGUUGCAC ACCUUUCC-3′ C16U 0.45
5′-GCCGU G CGUUGCAC ACCUUUCC-3′ C16G 0.73
5′-GCCGU G GGUUGCAC ACCUUU-3′ wt 0.89
5′-GCCGU G GGUUGCAC ACCU-3′ wt 1.0
5′-GCCGU G GGUUGCAC AC-3′ wt 0.67
Substrates maintained Watson–Crick or wobble base pairing with
mutant 1-9t constructs. Activity in single turnover kinetic assay is shown
relative to wild type 1-9t (wt) and 22-mer substrate (reaction conditions:
50 mM Tris–HCl, pH 7.5, 140 mM KCl, 10 mM NaCl, 1 mM MgCl2,
100 nM ribozyme, 5 nM substrate, 37°C). n.d., not determined.
Figure 9
Serum stability analysis of synthetic 1-9t motif. The assay was
performed as described in the Materials and methods section. RNase
T1 ladder shows position of G residues. 
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highly functionalized dUTP derivatives that are substrates
for thermostable DNA polymerases may yield new cata-
lysts soon [56].
Interestingly, only C-5 pyrimidine or C-8 purine modified
nucleoside triphosphates have been utilized to date for
the selection of the ribozyme motifs [57]. The chemistry
of functionalization for these positions of nucleic acid
bases is well developed and such substitutions are well
tolerated with polymerases utilized in in vitro selection
protocols. Unfortunately, modifications at these positions
of nucleotides in RNA and/or DNA usually do not
improve nuclease resistance.
We decided to search for new nuclease-resistant
phospodiesterases in 2′-NH2-C,U modified sequence
space for the following reasons: first, 2′-NH2-C,U modifi-
cation is known to confer nuclease resistance to RNA, and
related nucleoside triphosphates are compatible with
in vitro selection protocol [4,39]; second, because amines
react faster than alcohols with phosphoryl compounds but
form less stable adducts [58], there is a potential for more
rapid turnover in phosphoryl transfer through transient
covalent catalysis in 2′-NH2-C,U background; and third,
the 2′-NH2-C,U modified RNA forms duplexes with
lower thermodynamic stability than unmodified RNA
[41]. Therefore, 2′-NH2-C,U modified RNA should be
less prone to form stable alternative folds, and even if
these alternative conformers form, they can revert to the
active conformation with less energetic penalty than
unmodified RNA [59]. On the other hand, 2′-NH2-C,U
background may require more sequence space to support
thermodynamically stable structural elements needed for
the formation of a catalytic core and precise positioning
during catalysis. 
The nuclease resistance of the 1-9t motif in human serum
clearly highlights the advantages of using 2′-NH2-U,C
modifications versus unmodified pools for in vitro selection
of nuclease-resistant ribozymes. On the basis of currently
available structural and kinetic data it is difficult to con-
clude whether the 1-9t motif takes full advantage of the
present 2′-NH2 functionality for its catalytic mechanism.
The fact that ribozyme loses cleavage activity when CTP
is substituted for 2′-NH2-CTP indicates absolute require-
ments for 2′-NH2 functionality of cytidine residues;
however, we cannot distinguish if these groups are directly
involved in catalysis or play a critical structural role. 
The catalytic efficiency of the 1-9t ribozyme
(kcat/Km = 3.7 × 106 min–1 M–1) measured at ‘physiological
conditions’ is close to that of the optimized all-RNA ham-
merhead ribozyme. The parity with the hammerhead may
result from the incapability of 1-9t to take full advantage
of amino functionality under exerted selection pressure. It
is also possible that diminished thermodynamic stability
of 2′-NH2-U,C containing duplexes may offset potential
catalytic advantages offered by this functionality.
In the proposed secondary structure of the 1-9t ribozyme
(Figure 4, two stem–loops ‘clamping’ conserved catalytic
core dictate greater sequence requirements for support-
ing structural elements than compared with the hammer-
head, with one stem loop). At the same time, the number
of absolutely conserved residues (11–13 nucleotides) is
the same for the 1-9t motif (C17, C36–A42, G44–G46,
possibly G43 with C53) and hammerhead. Because
2′-NH2-group of uridine residues is not required for
catalysis, it is tempting to speculate that performing
selection in 2′-F-U, 2′-F-A and 2′-NH2-C background
may provide a smaller motif with similar catalytic rates or
a motif of the same size but faster rates, which will take
advantage of the increased thermodynamic stability of
2′-F-U,A containing duplexes and 2′-NH2 functionality
of cytidine residues.
It is also worth noting that all phosphodiester cleaving
ribozymes evolved to date by in vitro selection process,
even the one that utilizes histidine as a cofactor [60], can
not achieve a kcat of more than 0.1–0.2 min–1 at physiologi-
cal conditions. What can be done to allow RNA/DNA play
‘with the fuller deck’ [61] and evolve into more robust,
small and nuclease-resistant phosphodiesterases?
In addition to the insightful suggestions summarized by
Joyce [61], we believe that it is necessary to develop new
polymerizing enzymes that will allow to incorporate a
greater variety of modified triphosphates. In particular,
enzymes that would be able to incorporate triphosphates
with a combination of 2′ modifications, conferring nucle-
ase resistance, and functional modifications, projecting
desired groups (such as imidazole and carboxylate) from
C-4′ οr C-5′ of the sugar moiety and/or C-2 of the purine
base, in addition to C-5 and C-8 modifications, are highly
desirable. It is also important to develop new selection
strategies that would allow to ‘catch’ and amplify really
fast winners without using the manual techniques that
currently limit sampling time to 0.5–1 min.
Significance
We have demonstrated that nuclease-resistant
ribozymes can be directly evolved through in vitro selec-
tion. By using 2′-amino-pyrimidine triphosphates and a
T7 RNA polymerase, nuclease-stable ribozymes were
generated. By imposing desired selective pressure, we
were able to find a new motif that had optimal activity in
simulated physiological conditions. Moreover, this motif
showed minimal substrate recognition rules allowing for
a wide range of potential targets. The 1-9t motif was
shown to be amenable to truncation through rationally
designed deletion analysis. Application of the 1-9t motif
to human  pathological disease models will be indicative
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of the need to perform selections in a physiological envi-
ronment if a therapeutic nucleic acid enzyme is desired. 
The scope of nucleic acid phosphodiester cleavers now
includes ribozymes, DNA enzymes, 2′-amino
ribozymes, and derived chemically stabilized hybrid
molecules. The success of the in vitro selection approach
has enabled the exploration of new sequence space and
chemical functionality. Utilizing novel modifications of
nucleoside triphosphates and polymerases with relaxed
specificities, many more new catalysts will probably be
found. The only limit will be in what modification can
survive the constraints of the polymerases necessary for
in vitro selection.
Materials and methods
Oligonucleotides
DNA oligonucleotides were synthesized by Operon Technologies.
Template oligos were purified by denaturing polyacrylamide gel elec-
trophoresis (PAGE) and Sep-pak (Waters) chromatography columns.
RNA substrate oligos were synthesized at RPI, purified by denaturing
PAGE and ethanol precipitated. Substrates were 5′-end labeled with
gamma-32P-ATP and T4 polynucleotide kinase followed by denaturing
PAGE purification and ethanol precipitation.
Pool preparation
The initial pool DNA was prepared by converting the template oligo into
double-stranded DNA by fill-in with a Taq polymerase.
(Template = 5′-ACC CTC ACT AAA GGC CGT (N)40 GGT TGC ACA
CCT TTC-3′; primer 1 = 5′-CAC TTA GCA TTA ACC CTC ACT AAA
GGC CGT-3’; primer 2 = 5′-TAA TAC GAC TCA CTA TAG GAA AGG
TGT GCA ACC-3′.) 5 nmole of template, 10 nmole of each primer and
250 U Taq polymerase were incubated in a 10 ml volume with 1 × PCR
buffer (10 mM Tris-HCl, pH 8.3, 1.5 mM MgCl2, 50 mM KCl) and
0.2 mM of each dNTP as follows: 94°C, 4 min; (94°C, 1 min; 42°C,
1 min; 72°C, 2 min) × 4; 72°C, 10 min. The product was analyzed on
2% separide agarose gel for size and extracted twice with buffered
phenol, then chloroform-isoamyl alcohol, and ethanol precipitated. The
initial RNA pool was made by transcription of 500 pmole (3 × 1014 mol-
ecules) of this DNA as follows. Template DNA was added to 40 mM
Tris-HCl (pH 8.0), 12 mM MgCl2, 5 mM dithiothreitol (DTT), 1 mM sper-
midine, 0.002% Triton X-100, 1 mM LiCl, 4% PEG-8000, 10%
methanol, 2 mM ATP, 2 mM GTP, 2 mM 2′-amino-dCTP, 2 mM
2′-amino-dUTP, 5 U/ml inorganic pyrophosphatase and 5 U/µl T7 RNA
polymerase at room temperature in for a total volume of 1 ml. A separate
reaction contained a trace amount of α-32P-GTP for detection. Tran-
scriptions were incubated at 37°C for 2 h followed by addition of equal
volume STOP buffer (94% formamide, 20 mM EDTA, 0.05% bromophe-
nol blue). The resulting RNA was purified on a 6% denaturing PAGE
gel, followed by Sep-pak chromatography and ethanol precipitation.
Initial selection
2 nmole of 16 mer 5′-biotinylated substrate (5′-biotin-C18 linker-GCC
GUG GGU UGC ACA C-3′) was linked to 200 µl UltraLink immobi-
lized NeutrAvidin resin (400 µl slurry, Pierce) in binding buffer (20 mM
Na3PO4, pH 7.5, 150 mM NaCl) for 30 min at room temperature. The
substrate column was washed with 2 ml binding buffer followed by
2 ml column buffer (50 mM tris-HCl (pH 8.5), 100 mM NaCl, 50 mM
KCl). 1000 pmole of initial pool RNA in 200 µl column buffer was
added to the resin and incubated for 30 min at room temperature. The
column was subsequently washed with 2 ml column buffer. 200 µl
elution buffer (column buffer + 25 mM MgCl2) was added to the
column and allowed to incubate 30 min at room temperature. Eluent
was collected followed by three 200 µl elution buffer washes. The
eluent/washes were ethanol precipitated using 80 µg glycogen as
carrier and rehydrated in 50 µl sterile H2O. The eluted RNA was ampli-
fied by reverse transcription/PCR. 5–31 µl RNA was incubated with
20 pmol of primer 1 in 14 µl, at volume 90°C for 3 min, then placed on
ice for 1 min. The following reagents were added (final concentrations
noted): 1 × PCR buffer, 1 mM each dNTP, 2 U/µl RNase Inhibitor,
10 U/µl SuperScript II reverse transcriptase. The reaction was incu-
bated at 42°C for 1 h followed by 95°C for 5 min to inactivate the
reverse transcriptase. The volume was then increased to 100 µl by
adding water and reagents for PCR: 1 × PCR buffer, 20 pmol primer 2
and 2.5 U Taq DNA polymerase. The reaction was cycled in a Hybaid
thermocycler: 94°C, 4 min; (94°C, 30 sec; 54°C, 30 sec; 72°C, 1 min)
× 25; 72°C, 5 min. Products were analyzed on agarose gel for size and
ethanol precipitated. One-third to one-fifth of the PCR DNA was used
to transcribe the next generation, in a 100 µl volume, as described
above. Subsequent rounds used 20 pmol RNA for the column with
40 pmol substrate.
Two column selection
At generation 8, the column selection was changed to a two column
format. 200 pmoles of 22-mer 5′-biotinylated substrate (5′-biotin-C18
linker-GCC GUG GGU UGC ACA CCU UUC C-C18 linker-thiol modi-
fier C6 S-S-inverted abasic-3′) was used in the selection column as
described above. Elution was in 200 µl elution buffer followed by a 1 ml
elution buffer wash. The 1200 µl eluent was passed through a product
trap column by gravity. The product trap column was prepared as
follows: 200 pmol 16 mer 5′-biotinylated ‘product’ (5′-GGU UGC ACA
CCU UUC C-C18 linker-biotin-3′) was linked to the column as
described above and the column was equilibrated in elution buffer.
Eluent from the product column was precipitated as previously
described. The products were amplified as above only with 2.5 times
more volume and 100 pmol each primer. 100 µl of the PCR reaction
was used to do a cycle course; the remaining fraction was amplified
the minimal number of cycles needed for product.
Cloning and sequencing
Generations 13 and 22 were cloned using Novagen’s Perfectly Blunt
Cloning kit (pT7Blue-3 vector) following the kit protocol. Clones were
screened for insert by PCR amplification using vector-specific primers.
Positive clones were sequenced using ABI Prism 7700 sequence
detection system and vector-specific primer. Sequences were aligned
using MacVector software; two-dimensional folding was done using
Mulfold software [46]. Individual clone transcription units were con-
structed by PCR amplification with 50 pmol each of primer 1 and
primer 2 in 1 × PCR buffer, 0.2 mM each dNTP and 2.5 U of taq poly-
merase in 100 µl volume cycled as follows: 94°C, 4 min; (94°C, 30 s;
54°C, 30 s; 72°C, 1 min) × 20; 72°C, 5 min. Transcription units were
ethanol precipitated, rehydrated in 30 µl H2O and 10 µl was tran-
scribed in 100 µl volume and purified as previously described. 
Kinetic analysis
Single turnover kinetics were performed with trace amounts of 5′-32P-
labeled substrate and 10–1000 nM pool or ribozyme. 2 × substrate in
1 × buffer and 2 × pool/ribozyme in 1 × buffer were incubated sepa-
rately at 90°C for 3 min followed by equilibration to 37°C for 3 min.
Equal volume of 2 × substrate was added to pool/ribozyme at t0 and
the reaction was incubated at 37°C. Time points were quenched in
1.2 volume of STOP buffer on ice. Samples were heated to 90°C for
3 min prior to separation on 15% sequencing gels. Gels were imaged
using a phosphorimager and quantitated using ImageQuant software
(Molecular Dynamics). Curves were fit to double-exponential decay in
most cases, although some of the curves required linear fits. 
Gel shift analysis
Kd was measured by gel shift analysis in pool/ribozyme excess [62,63].
2 × ribozyme/pool was incubated for 3 min at 25°C in 50 mM Tris–HCl
(pH 8.5), 100 mM NaCl, 50 mM KCl, 5% sucrose, 0.02% bromophe-
nol blue, and 0.02% xylene cyanol. 2 × 32P-substrate or product (trace)
was incubated in the same conditions separately. Equal volume 2 ×
substrate or product was added to the ribozyme/pool tube and allowed
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to equilibrate at 25°C for 30 min. The complex was loaded onto a 12%
nondenaturing temperature-controlled PAGE gel running at 20 W. The
gel and running buffer contained 50 mM Tris-acetate (pH 8.5), 100 mM
NaCl, and 50 mM KCl. Gel buffer was recirculated throughout the run
by a peristaltic pump to keep pH constant. Ribozyme/pool concentra-
tions over 4 logs were used to determine Kd. Gels were quantitated as
described above and curves were fit to theorhetical binding curves.
Ribozyme stability analysis
Briefly, 100 pmoles of starting material was end-labeled with 
[γ-32P]ATP. This end-labeled material was combined with 500 pmoles
of unlabeled (cold) ribozyme. The mixture was dried down and resus-
pended in 20 µl of fresh 100% human serum. The suspension was
incubated at 37°C for 23.3 h. Aliqouts (2 µl) of the reaction were
removed at 0, 0.25, 0.5, 0.75, 1, 2, 4, 8 and 23.3 h. The reaction
aliquots were immediately quenched by removal into 5 µl of 95% for-
mamide, 20 mM EDTA, 0.05% bromphenol blue and 0.05% xylene
cyanol on ice. A portion of each time point was counted in a scintilla-
tion counter for normalizing counts per lane. The time points were
heated to 95°C for 1 min and loaded onto a denaturing 20% polyacry-
lamide gel at 106 cpm per lane. Intact ribozyme and the specific RNA
degradation products generated by exposure to ribonucleases in the
serum were visualized by scanning a phosphorimager screen which
had been exposed to the assay gel. The fraction of full-length ribozyme
at each time point was determined by phosphor imager quantitation of
bands representing the intact ribozyme and it’s degradation products.
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